Synchron - Bryant McGill

# Synchron **Entity class:** Brain-computer interface company **Domain:** Endovascular Brain-Computer Interfaces / Clinical Neurotechnology **Doc Type:** Company and Platform Node **Maturity:** Clinical-stage **Primary Sources:** [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]]; [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] ## Definition **Synchron** is a brain-computer-interface company developing the **Stentrode**, an electrode array delivered through the vascular system and deployed in a cerebral venous structure near motor cortex. It represents an endovascular access geometry: lower procedural burden and lower channel count than penetrating intracortical arrays, with the tradeoff of recording through vessel tissue. ## Platform role The Stentrode is paired with implanted and external components that relay recorded motor signals to decoding software. The cluster treats Synchron as a counter-geometry to [[wiki/Neuralink|Neuralink]]: it tests whether useful, stable neural control can be achieved without open-brain insertion of penetrating arrays. Synchron is also the first platform routed here through Apple's [[wiki/BCI Human Interface Device Protocol|BCI Human Interface Device protocol]]. That interface places neural control inside an operating-system accessibility layer, allowing supported devices to operate ordinary applications through the same abstraction used by other assistive inputs. ## Provenance and Development Thomas Oxley conceived the Stentrode approach in 2007 at the University of Melbourne, filed the first patent in 2010, and carried the program from Australian research into Synchron’s U.S. clinical and regulatory organization. The technology descends from interventional cardiology and neurointervention: a catheter delivers an electrode-bearing stent through the vasculature rather than placing a penetrating array through an open cranium. Synchron’s $200 million Series D, announced 6 November 2025, was raised to fund a pivotal trial and commercial preparation. These origin, lineage, and financing claims are `VERIFIED` in the packet sources. ## Applications in Use Synchron’s investigational system has been assessed in Australian and U.S. trials for digital-device control by people with paralysis. The six U.S. COMMAND participants met the study’s twelve-month primary safety endpoint as reported in September 2024. In August 2025, a participant with ALS used the Stentrode through Apple’s BCI Human Interface Device protocol to navigate an iPad, open applications, and compose text. ## Forward Capability The principal scaling variable is **regulatory precedent for a permanently implanted endovascular BCI**. The device’s lower-bandwidth access geometry composes with operating-system-level input support: once neural intent is represented as a native input class, every compatible application becomes part of the reachable surface. Synchron states a clinical-first path while treating consumer, workplace, and military use as later domains. ## Open Questions Pivotal-trial enrollment, endpoints, and the eventual premarket-approval classification remain the settlement records for commercial readiness. Published long-term signal-quality and explant data would establish how the endovascular geometry performs beyond the current safety window. ## Sources - [Synchron — technology and current investigational status](https://synchron.com/technology) - [Synchron — company news, including the Apple BCI HID demonstration](https://synchron.com/news) - [IEEE Pulse — interview with Thomas Oxley](https://www.embs.org/pulse/articles/with-synchron-ceo-tom-oxley/) ## Relationships **Related cluster nodes:** [[collections/Neurotech|Neurotech]] · [[wiki/Brain-Computer Interfaces|Brain-Computer Interfaces]] · [[wiki/Invasive BCI|Invasive BCI]] · [[wiki/Neuralink|Neuralink]] · [[wiki/Precision Neuroscience|Precision Neuroscience]]  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### People and institutional relationships - **Synchron** was founded and led by [[wiki/Tom Oxley|Tom Oxley]]. ### Technology and research relationships - **Synchron** develops [[wiki/Stentrode|Stentrode]]. Endovascular BCI via cerebral blood vessel. - **Synchron** integrates with [[wiki/Apple device ecosystem|Apple device ecosystem]]. BCI HID/Switch Control lineage; source corpus documents 2025 native integration. - **Synchron** is associated with sensing + models + interactions. Useful ontology for decoders and interaction pages. ### Key Relationships - **Synchron** is associated with interventional/endovascular. Avoids open-brain surgery. ### Additional Documented Relationships - **Synchron** integrates with [[wiki/Apple|Apple]]. BCI HID/Switch Control lineage. source corpus documents 2025 native integration. - [[wiki/BCI Operating-System Substrate|BCI Operating-System Substrate]] is bridged through **Synchron**. Treat OS/API layer as its own wiki entry. not a Synchron footnote. - The source corpus interprets the relationship this way: [[wiki/Less-Invasive Brain-Computer Interface|Less-Invasive Brain-Computer Interface]] is bridged through **Synchron**. Different access geometries solving common surgery/bandwidth trade-space.  ## Related Work in the Corpus  - In [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]], **Movement VII — Interface Deployment: The Neurointerface Stack from Wearable to Implanted** provides the narrative context for **Synchron**: Wiki route: brain-computer interfaces · non-invasive BCI · invasive BCI · Neuralink · Synchron · Precision Neuroscience · Blackrock Neurotech · Paradromics · BCI HID. - In [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], **Synchron: The Minimally Invasive Counter-Geometry** provides the narrative context for **Synchron**: Synchron, Inc., founded and led by CEO Dr.  ## Research Edges  #### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 298 — `founded_and_led_by` → [[wiki/Tom Oxley|Tom Oxley]]** — **CORPUS**; evidence `CORPUS_BCI`, `SYNCHRON_HOME`. - **Edge 299 — `develops` → [[wiki/Stentrode|Stentrode]]** — **VERIFIED**; evidence `SYNCHRON_TECH`. Endovascular BCI via cerebral blood vessel. - **Edge 300 — `access_geometry` → interventional/endovascular** — **VERIFIED**; evidence `SYNCHRON_HOME`, `SYNCHRON_TECH`. Avoids open-brain surgery. - **Edge 301 — `integrates_with` → [[wiki/Apple|Apple device ecosystem]]** — **CORPUS**; evidence `CORPUS_BCI`. BCI HID/Switch Control lineage; source corpus documents 2025 native integration. - **Edge 302 — `research_domains` → sensing + models + interactions** — **VERIFIED**; evidence `SYNCHRON_RESEARCH`. Useful ontology for decoders and interaction pages. #### Incoming typed edges - **Edge 410 — [[wiki/Less-Invasive Brain-Computer Interface|less-invasive BCI]] `bridge_entities` → this entry** — **ANALYTIC**; evidence `SYNCHRON_TECH`, `SUB_TECH`, `MERGE_OPENAI`, `PRECISION_VISION`. Different access geometries solving common surgery/bandwidth trade-space. - **Edge 413 — [[wiki/BCI Operating-System Substrate|operating-system BCI integration]] `bridge_entities` → this entry** — **CORPUS**; evidence `CORPUS_BCI`, `CORPUS_ATLAS`. Treat OS/API layer as its own wiki entry, not a Synchron footnote.   #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 298 — `founded_and_led_by` → [[wiki/Tom Oxley|Tom Oxley]]** — **PRIOR_NEUROTECH_CORPUS**; evidence `CORPUS_BCI`, `SYNCHRON_HOME`. - **Edge 299 — `develops` → [[wiki/Stentrode|Stentrode]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `SYNCHRON_TECH`. Endovascular BCI via cerebral blood vessel. - **Edge 300 — `access_geometry` → interventional/endovascular** — **PRIOR_NEUROTECH_VERIFIED**; evidence `SYNCHRON_HOME`, `SYNCHRON_TECH`. Avoids open-brain surgery. - **Edge 301 — `integrates_with` → [[wiki/Apple device ecosystem|Apple device ecosystem]]** — **PRIOR_NEUROTECH_CORPUS**; evidence `CORPUS_BCI`. BCI HID/Switch Control lineage; source corpus documents 2025 native integration. - **Edge 302 — `research_domains` → sensing + models + interactions** — **PRIOR_NEUROTECH_VERIFIED**; evidence `SYNCHRON_RESEARCH`. Useful ontology for decoders and interaction pages.  ## Research Inferences  These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. The interpretive frame comes from [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0051 — Established.** The Stentrode reaches cortex through a cerebral vein, importing catheter technique from interventional cardiology into neurotechnology. The significance is procedural rather than electrical: it makes neural access a same-day interventional procedure performed by a specialty that already exists in every major hospital.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0052 — Strongly indicated.** The vasculature is a pre-existing distribution network reaching every cubic millimeter of brain, which means an endovascular modality's ceiling is set by how small a device can be delivered through progressively finer vessels. Miniaturization, not surgery, is that lineage's entire roadmap. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0053 — Established.** Oxley conceived the Stentrode in 2007, filed in 2010, moved to the United States in 2015 and raised capital in 2016 — a nineteen-year arc from concept to a pivotal trial. That cadence is the realistic clock for any neural-interface modality, and it should anchor every timeline estimate in the corpus. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0054 — Established.** Six patients holding a primary safety endpoint across twelve months with no vascular or brain events is the evidentiary object that permits a pivotal trial. Safety-first sequencing means the field's efficacy data will arrive suddenly and late, which is why capability appears to jump rather than climb. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0055 — Strongly indicated.** The first PMA for a permanently implanted BCI creates the classification template every subsequent device is measured against. Regulatory precedent is a form of standards authorship, and it is being competed for by a small number of firms on a two-to-three-year horizon. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0056 — Analytic.** A nitinol stent scaffold carrying electrodes is a cardiology material doing neuroscience work, which means the device's reliability data inherits decades of vascular-implant experience. Borrowed reliability is the quiet advantage of modality transfer between clinical disciplines. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0059 — Strongly indicated.** Building a patient registry before a pivotal trial is an assertion that enrollment, not evidence, is the binding constraint. Registries are also longitudinal cohorts, and a longitudinal cohort of interfaced humans is the substrate on which every population-level claim about neural data will eventually rest. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0060 — Plausible.** Scaling any implanted interface to millions requires a trained procedural workforce, and the endovascular route is the only one that can borrow an existing one. Workforce availability, not device manufacturing, will gate deployment volume in the 2030s. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0063 — Strongly indicated.** ADAPT-PD evaluated adaptive stimulation in clinical *and home* settings across 68 patients over a year, which means the dataset includes unsupervised daily life. Continuous neural telemetry outside the clinic is the precondition for every longitudinal model of a person's neural state. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0064 — Analytic.** Cutting initial programming time by 85% through automated electrode selection moves clinical judgment into an algorithm. Each such move raises the fraction of the therapy defined by the manufacturer's model rather than by the attending physician, which is a governance shift dressed as a workflow improvement. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0069 — Established.** The academic neuromodulation laboratories that validated adaptive stimulation are the same ones supplying the clinical leadership of the implant industry. The people are the transfer mechanism, and the transfer is documented in trial authorship. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0070 — Plausible.** A device that continuously tunes itself to an individual's fluctuating state is maintaining a personal model that no clinician possesses. Over years, that model becomes a more detailed record of the person's neural dynamics than any medical record, and its custody is unaddressed. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0073 — Established.** Epidural spinal stimulation has restored volitional movement after complete injury by amplifying residual descending signal. The nervous system tolerates an external controller inserted mid-pathway, which is direct evidence that mediated function is functionally continuous with native function. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]]